What you should know:
1. Dr. Bundschu was part of the nine-physician team behind the study.
2. The cohort studied Nevro’s HF10 technology.
3. This was the first large-scale observational study on the effectiveness of HF10 spinal cord stimulation technology.
More articles on orthopedics:
Legislation, bundled payments may be stabilizing neurosurgery reimbursement
Indiana spine, neurosurgeon group refuses to become employed at IU Health, jeopardizing relationships: 5 details
Stryker aims to make a new spine acquisition in the next 6 months, K2M integration on track
